The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Haha cymru. That's hilarious. Like it.
I like the logic Cymru - hopefully celebrate.
I agree I think the deal is done and has been for some time it is just the fine tuning of the legals and the re-admission details which are holding things up.
maybe they are waiting for the pubs to re open ahead of the next announcement so we can all celebrate in style!.....or drown our sorrows, nope lets go glass half full and go with celebrate in style!
I'll echo that comment OzaryK. I think it was selected last year. Certainly must have been known in the summer.
Whilst there's been comments passed on it was too expensive and dropped I don't think that was the case. I just think there might have been other factors contributing towards the delays.
Judging by the last update, we must be nearly there by now surely?
I hope it delivers this month and we all become lucky shareholders!
Just a guess here, but with some degree of conviction, this is deffo not going to be stemprinter. I believe the target was chosen a long while back, noting that the interest with Tils has only surfaced recently. Having said that, i do believe that any incomig news will be positive, just cant see it being this one. Hopefully some good news in the next few weeks, good luck whatever the target.
From Tizianas own Final Results RNS 18th June (two weeks ago) :
"The diagnostic has a unique biological basis, being based on the detection of cancer stem cell markers, uses a reliable platform (qRT- PCR, FFPE), and has been evaluated in an initial retrospective validation study using a consecutive cohort of approximately 2,400 patients with breast cancer."
" We are continuing development of StemPrint ER diagnostic tester. Recently, StemPrintER results were announced, from a poster selected for discussion session at the American Society of Clinical Oncology (ASCO) "
If Cerrone himself makes reference to STEM as a diagnostic tool... That's good enough for me, and probably Syms too.
The" specific cancer" that Syms makes reference too in our most recent RNS isn't breast cancer... But more specifically recurrent metastasis... Whereby early detection and treatment is absolutely key if the patient is to survive.